Can-Fite: Reports Progress in the Development of Piclidenoson for Osteoarthritis in Pets Through its Partner Vetbiolix - Form 6-K
Can-Fite: Reports Progress in the Development of Piclidenoson for Osteoarthritis in Pets Through its Partner Vetbiolix ● ... | August 17, 2022
United States Fite Biopharma Motti Farbstein Exchange Commission Development Of Piclidenoson Fite Biopharma Ltd
Source: marketscreener.com